Loading companies…
Denmark · Biotech
Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series C | $75M | Bpifrance — Role not disclosedDawn Biopharma — Role not disclosedEIFO — Role not disclosedGilde Healthcare — Role not disclosedHealthCap — Role not disclosedJeito Capital — Role not disclosedLogos Capital — Role not disclosedNovo Holdings — Role not disclosedOrbiMed — Role not disclosedPontifax Venture Capital — Role not disclosedRA Capital Management — Role not disclosedSurveyor Capital — Role not disclosedTCGX — Role not disclosedTPG — Role not disclosedVenrock — Role not disclosedVida Ventures — Role not disclosedYsios Capital — Role not disclosed |